Trial Profile

Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive

Status: Recruiting

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs NWRD-08 (Primary)
Indications Human papillomavirus infections; Squamous intraepithelial lesions of the cervix
Focus First in man; Therapeutic Use
Sponsors Newish Technology (Beijing)

Most Recent Events

24 Jul 2023 According to a Newish Technology media release, 7 subjects have been enrolled in this IIT clinical study.
22 Jul 2023 According to a Newish Technology media release, the company has submitted IND application to CDE this year and has received clinical trial acceptance notice.
22 Jun 2023 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com